[VIVO] YoY Annual Result on 30-Sep-2016 [#FY]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
29-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#FY]
Profit Trend
YoY- -9.32%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Annual Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 201,014 213,571 200,771 196,082 194,830 188,832 188,686 1.05%
PBT 31,557 30,380 36,429 50,644 55,063 52,108 57,362 -9.47%
Tax 7,175 6,531 14,872 18,415 19,523 17,365 19,330 -15.21%
NP 24,382 23,849 21,557 32,229 35,540 34,743 38,032 -7.13%
Tax Rate -22.74% -21.50% -40.82% -36.36% -35.46% -33.33% -33.70% -
Total Cost 176,632 189,722 179,214 163,853 159,290 154,089 150,654 2.68%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 12.13 11.17 10.74 16.44 18.24 18.40 20.16 -8.11%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS 0.57 0.56 0.51 0.77 0.85 0.84 0.92 -7.66%
EPS Diluted 0.57 0.56 0.51 0.76 0.85 0.83 0.91 -7.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.